A phase I study of IMGN529, an antibody-drug conjugate (ADC) targeting CD37, in adult patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) Meeting Abstract
| Authors: | Stathis, A.; Freedman, A. S.; Flinn, I. W.; Maddocks, K. J.; Weitman, S.; Berdeja, J. G.; Mejia, A. V.; Zucca, E.; Green, R.; Romanelli, A.; Zildjian, S. H.; Ruiz-Soto, R.; Palomba, L. |
| Abstract Title: | A phase I study of IMGN529, an antibody-drug conjugate (ADC) targeting CD37, in adult patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243506191 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.1760.1760 |
| Notes: | Meeting Abstract: 1760 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
